Researchers find the key to loss of smell with Parkinson's disease
University of Auckland research has found an anatomical link for the loss of the sense of smell in Parkinson's disease.
Sep 18, 2017
0
233
University of Auckland research has found an anatomical link for the loss of the sense of smell in Parkinson's disease.
Sep 18, 2017
0
233
Several neurodegenerative disorders are caused by aggregates of a single protein known as alpha-synuclein. In collaboration with CNRS and the University of Antwerp, KU Leuven neurobiologists have discovered that the shape ...
Jun 10, 2015
1
448
Markers that indicate the presence of Parkinson's disease in patients on average seven years before clinical presentation have been identified by a UCL and Moorfields Eye Hospital research team.
Aug 21, 2023
0
338
After Alzheimer's, Parkinson's is the most common neurodegenerative disease in the world. More than six million people worldwide suffer from it. In this disease, alpha-synuclein proteins form thread-like structures called ...
Nov 15, 2022
0
980
Past neuroscience research consistently found a link between deviations from the "normal" iron metabolism, also known as iron dysregulation, and different neurodegenerative diseases, including Parkinson's disease (PD) and ...
A new Parkinson's disease clinical trial with patients wearing laser light helmets has shown "promising results," as the therapy helped "improve motor function" for those facing the progressive neurological condition.
Apr 28, 2023
0
9
A molecule that shows promise in preventing Parkinson's disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.
Dec 9, 2021
0
290
For more than five years, urine and cerebral-spinal fluid samples from patients with Parkinson's disease have been locked in freezers in the NINDS National Repository, stored with the expectation they might someday help unravel ...
Jul 5, 2016
0
1028
Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson's disease. Preclinical tests show that the new treatment approach is not only safe ...
Apr 1, 2022
0
45
Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson's disease have a clear "genetic signature" of the disease in their memory T cells. The scientists hope that targeting these genes ...
Mar 21, 2022
0
141